Short communication
Author links open overlay panel, , , , , , , , , , , , , , , , , , , ...
Abstract
The hepatoprotective effects of a newly synthesized 15 amino acid fragment code named BPC 157 was evaluated in comparison with the reference standards (bromocriptine, amantadine and somatostatin) in various experimental models of liver injury in rats: 24 h-bile duct + hepatic artery ligation 48 h-restraint stress and CCl4 administration. BPC 157 administered either intragastrically or intraperitoneally, significantly prevented the development of liver necrosis or fatty changes in rats subjected to 24 h bile duct + hepatic artery ligation, 48 h-restraint stress, CCl4 treatment (1 ml/kg i.p., sacrifice 48 h thereafter). The other reference drugs had either little or no protective actions in these models. Noteworthy, the laboratory test results for bilirubin, SGOT, SGPT fully correlated with the macro/microscopical findings. Thus, on the basis of consistent protective eefect of BPC 157, possible clinical application in liver diseases is now warranted.
References (20)
et al.
J. Hepatol.
(1991) M.O. Thorner
Lancet
(1975) M. Uribe et al.
Gastroenterology
(1979) A. Pár et al. A. Pár
Exp. Clin. Gastroenterol.
(1992) G. Nordstorm et al.
Surgery
(1985) H. Hirsawa et al.
Surgery
(1987) S. Szabo et al.
Experimentia
(1982) P. Sikiric et al.
Dig Dis Sci
(1990) P. Sikiric et al.
Exp. Clin. Gastroenterol.
(1991)
There are more references available in the full text version of this article.
View full text